ArticleHealthcare technology letters2021
Down-sampling template curve to accelerate LDDMM-curve with application to shape analysis of the corpus callosum.
Article in Healthcare technology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Down-sampling template curve to accelerate LDDMM-curve with application to shape analysis of the corpus callosum.Healthcare technology letters · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large deformation diffeomorphic metric mapping for curve (LDDMM-curve) has been widely used in deformation based statistical shape analysis of the mid-sagittal corpus callosum. A main limitation of LDDMM-curve is that it is time-consuming and computationally complex. In this study, down-sampling strategies for accelerating LDDMM-curve are investigated and tested on two large datasets, one on Alzheimer's disease (155 Alzheimer's disease, 325 mild cognitive impairment and 185 healthy controls) and the other on first-episode schizophrenia (92 first-episode schizophrenia and 106 healthy controls). For both datasets a variety of down-sampling factors are tested in terms of registration accuracy, registration speed, and most importantly disease-related patterns. Experimental results revealed that down-sampling template curve by a factor of 2 can significantly reduce the running time of LDDMM-curve without sacrificing the registration accuracy. Also, the disease-induced patterns, or more specifically the group comparison results, were almost identical before and after down-sampling. It is also shown that there was no need to down-sample the target population curves but only the single template curve of the study of interest. Comprehensive analyses were conducted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.